Navigation Links
ViaViente Demonstrates Cardiovascular Benefits in New Human Trial
Date:8/8/2008

By Kathleen J. Burkhalter

BOSTON, Aug. 8 /PRNewswire/ -- Francis, 50, never imagined that drinking a high anti-oxidant fruit beverage every day could help protect his health -- in just 1 week. That's what he found out after participating in a clinical trial near his home in Los Angeles, Calif.

A new study conducted by Bell Ventures, shows that after just 7 days, platelet aggregation, a known indicator of cardiovascular disease (CVD), was significantly reduced in many of the participants who took the anti-oxidant product, ViaViente, twice a day.

David Bell, President of Bell Ventures, said, "These results are important because they show how a natural anti-oxidant and anti-inflammatory product like ViaViente can help protect against one of our most serious health concerns."

Health experts recommend a daily intake of anti-oxidants, especially in their natural form. Oxidative stress causes damage to cells and contributes to aging and disease. Anti-oxidants combat effects of oxidative stress such as inflammation.

A recent independent report, A Consumer Conscious Look at Six Premium Anti-Oxidant Products, by Frank Ervolino, ND, shows that ViaViente outperformed other popular products using ORAC -- an industry standard for anti-oxidant testing. This is an important indication of quality and potential benefits.

Clinical research shows the connection between what's in the product and actual outcomes in human health.

The ViaViente study takes direct aim at the benefits to cardiovascular health of consuming a non-drug, natural food product. It correlates the consumption of ViaViente to platelet inhibition -- a marker of CVD.

Why is cardiovascular health so important? The American Heart Association reports that approximately 80 million people in the United States have CVD; nearly 2,400 people die of CVD every day; more people die from CVD than from cancer, auto accidents, and Type 2 diabetes com
'/>"/>

SOURCE Bell Ventures LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
10. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
11. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ewswire/--Sarnova,Inc.,thenation,sleadingspecialty...alservices(EMS)andrespiratorymarkets,announcedtoda...mentteam.ThenewexecutivesincludeTomDavid,executive...entandgeneralcounsel;SteveLacke,executivevicepresi...sidentofcorporatedevelopment. ,, "Ihaveworkedwi...
(Date:11/23/2009)...ire/--ProteonTherapeutics,Inc.,hasinitiatedaPhase1...-stagerenaldisease(ESRD)patientsundergoingsurgeryf...sentsProteon,ssecondhumanclinicalstudyinhemodialys...se1/2studyofPRT-201inESRDpatientsundergoingsurgery...r.ProteonalsoannouncestheappointmentofboardmemberG...
(Date:11/23/2009)...irstCall/--CordBloodAmerica,Inc.(OTCBulletinBoard:...pany( http://www.cordblood-america.com )focusedonb...alinsurancepolicy,tofamiliesnationwideandinternati...wwithCEOandco-founderMatthewSchisslerisnowavailabl...le/2875811 . ,, Intheinterview,Mr.Schisslerupda...
Breaking Medicine Technology:Sarnova Expands Senior Management Team 2Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients 2Fewer Dying Now From Abdominal Aortic Aneurysms 50813 1Fewer Dying Now From Abdominal Aortic Aneurysms 50813 2NCI renews Mayo Clinic Cancer Center support grant extends comprehensive status 50811 1NCI renews Mayo Clinic Cancer Center support grant extends comprehensive status 50811 2Purdue researchers create prostate cancer homing device for drug delivery 50809 1Purdue researchers create prostate cancer homing device for drug delivery 50809 2Purdue researchers create prostate cancer homing device for drug delivery 50809 3Purdue researchers create prostate cancer homing device for drug delivery 50809 4
... N.J., May 18, 2007 /PRNewswire-FirstCall/ -- A to...l studies with,Schering-Plough,s hepatitis product... and REBETOL(R) (ribavirin, USP) combination,thera...as well as,boceprevir (SCH 503034), the company,s ...tly in Phase II clinical development, will,be pres...
...(BUSINESS WIRE)--May 21, 2007 - Roche today announ...l patients who,discontinued treatment with Peg-Int...o adverse events within the first 12 weeks, were,a...(R),(peginterferon alfa-2a) and ribavirin. Further... on and complete a full course of,treatment with P...
Other Medicine Technology:Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 2Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 4Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 5Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 6Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 7Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 2Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 3Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 4Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 5Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 6
(Date:11/23/2009)...wswire/--Hazelden,theinternationallyrenownednonpro...rshipteamforitsnewrecoverycenterinNaples,Florida.H...lateMarch2010,andwillinitiallyprovideaddictiontrea...andoutpatientservices. ,, MichaelDemask,Ph.D.,w...aples,withBrendaIliff,M.A.,L.A.D.C.,asclinicaldire...
(Date:11/23/2009)...mSupportsFutureLeadersinSTEMFields ,, Scholar...n ceS c holars.org ,, WASHINGTON,No...ountusin.Withourcommunity,foundation,andcorporatep...ate,"saidAdolphP.Falcon,SeniorVicePresidentoftheNa...teHousemeetingtodaywherePresidentObamaannouncedthe...
(Date:11/23/2009)...re/--CortivaInstituteTucsonwillhostanIntroductiont...theschool,s6390EastBroadwayBlvd.location,whichwill...icebasicmassagestrokes. ,, "Massagetherapyisagr...longwithit,"saidJoannMcMaster,presidentofCortivaIn...or,s2009-2010OccupationalOutlookHandbookstatesthat...
(Date:11/23/2009)...Howistheeconomyaffectingpeople,swellness?According...ss&theEconomy,theeconomyismakinguscollectively...exerciseanddiettoonethatismoreinwardlyfocusedonada...tdramaticfindingwasthechangeinconsumers,definition...thandwellbeingtotoday,smorerelevantconcernsaboutad...
(Date:11/23/2009)...errors self-reported by American surgeons are stro... findings appear today in the online edition of A...ded collaborators from Johns Hopkins and the Ameri...l study, nearly 9 percent of U.S. surgeons respond...hs prior to being surveyed. Over 70 percent attrib...
Breaking Medicine News(10 mins):Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3Health News:Burnout and mental distress strongly related to errors by US surgeons 2
... Although the median price ...ively stable since January, 2009 (1 April, 09 Bloo...ast year, and the NZ dollar decline of between 16 ...erty in the South Island. , ...
... Medtral New Zealand offers...ican patients seeking a viable, safe alternative t... Long Beach, CA (PRWEB) April 8, 2009 --...ry as he has no health insurance. At the same time...
...Multiple, anatomically distinct lung cancer tumors...ccording to a retrospective analysis of patient tu...of the Journal of the National Cancer Institute. ...n appearance, it has been unclear whether they ari...
...ouncil Will Hear Public Comments on Comparative Ef...t , , ROCKVILLE, Md., April 7 The Federal Coordi...rch will hold a public listening session on April ...es. , , "The Obama Administration is committed to...
...h-intensity early treatment may lead to more inter...Y, April 7 (HealthDay News) -- More intensive trea...early bladder cancer doesn,t appear to improve pat...he average cost of care for patients who received ...
...Modern moms and dads snap thousands of photos, rec...o crawl. Until now, this frenzy of activity could ...ing their child,s health and developmental progres...letters, and at the same time tracks a child,s dev...
Other Medicine News:Health News:New Zealand Beach Front Property Offers Global Currency Rate Bargains 2Health News:A New Zealand Experience That Improves Lives: Arizona Man Finds Affordable, Quality Healthcare and Freedom From Constant Hip Pain on Recent Trip 2Health News:A New Zealand Experience That Improves Lives: Arizona Man Finds Affordable, Quality Healthcare and Freedom From Constant Hip Pain on Recent Trip 3Health News:Multifocal lung cancers appear to originate from single cancer clone 2Health News:Federal Coordinating Council on Comparative Effectiveness Research to Hold Public Listening Session in Washington, DC 2Health News:Intensive Early Treatment Doesn't Help Bladder Cancer Survival 2Health News:Digital album puts focus on kids' health 2Health News:Digital album puts focus on kids' health 3
Lyphochek Coagulation Control
...ance Specimens are intended for use in assessing c...n guidelines, including chain of custody, for Fede...he Substance Abuse and Mental Health Services Admi...artment (HHS) and other federal agencies. These sa...
Lyphochek Hemoglobin A2 Control
Liquichek Reticulocyte Control
Medicine Products: